Research programme: bryostatin analogues - Neurotrope/Stanford University

Drug Profile

Research programme: bryostatin analogues - Neurotrope/Stanford University

Alternative Names: Bryologs; Bryostatin analogues - Neurotrope/Stanford University

Latest Information Update: 02 Aug 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Stanford University
  • Developer Neurotrope BioScience
  • Class Antidementias; Macrocyclic compounds; Neuroprotectants
  • Mechanism of Action Protein kinase C stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Alzheimer's disease; Brain injuries; Fragile X syndrome; Niemann-Pick disease type C; Rett syndrome; Stroke

Most Recent Events

  • 25 Jul 2018 Preclinical trials in Niemann-Pick disease type C in USA (unspecified route)
  • 25 Jul 2018 Preclinical trials in Rett syndrome in USA (unspecified route)
  • 02 Mar 2016 Preclinical trials in Alzheimer's disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top